YU Shengyun,SONG Yanhua.Research progress of traditional Chinese medicine for non⁃obese polycystic ovary syndrome[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(5):87-90.
YU Shengyun,SONG Yanhua.Research progress of traditional Chinese medicine for non⁃obese polycystic ovary syndrome[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(5):87-90. DOI: 10.16305/j.1007-1334.2023.2205071.
Research progress of traditional Chinese medicine for non⁃obese polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is a common reproductive and endocrine metabolic disorder in women of childbearing age. Due to a highly heterogeneous clinical presentation, PCOS has two phenotypes: obese and non-obese. Hyperandrogenemia and related clinical manifestations are the key pathological features that distinguish obese PCOS from non-obese PCOS, and treatment should vary accordingly. The research progress of TCM treatment of non-obese PCOS is reviewed from three aspects: etiology and pathogenesis, clinical research, and mechanism research. The core pathogenesis of non-obese PCOS is kidney deficiency and liver depression. Traditional Chinese medicine therapy(herbal formulas, single herbs, and acupuncture) can effectively regulate menstrual cycle and sex hormone levels in non-obese PCOS patients, increase ovulation rate, improve clinical manifestations of hyperandrogenism such as hirsutism and acne, increase pregnancy rate and improve pregnancy outcome. The therapeutic mechanism may be related to the regulation of the body’s gut microbiota, inflammatory cytokines, nerve growth factors, and the hypothalamic-pituitary-ovarian axis.
关键词
多囊卵巢综合征高雄激素血症不孕肾虚肝郁证中药针灸肠道菌群
Keywords
polycystic ovary syndromehyperandrogenemiainfertilitykidney deficiency and liver depression syndrometraditional Chinese herbal medicineacupuncturegut microbiota
references
YE W, XIE T, SONG Y, et al. The role of androgen and its related signals in PCOS[J]. J Cell Mol Med, 2021, 25(4): 1825-1837.
KHAN M J, ULLAH A, BASIT S. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives[J]. Appl Clin Genet, 2019, 12: 249-260.
SANCHEZ-GARRIDO M A, TENA-SEMPERE M. Metabolic dysfun-ction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies[J]. Mol Metab, 2020, 35: 100937.
GONZÁLEZ F. Nutrient-induced inflammation in polycystic ovary syndrome: role in the development of metabolic aberration and ovarian dysfunction[J]. Semin Reprod Med, 2015, 33(4): 276-286.
ALI A I, NORI W. Correlation of serum visfatin level in non-obese women with polycystic ovary syndrome and matched control[J]. Reprod Sci, 2022, 29(11): 3285-3293.
ROSENFIELD R L, EHRMANN D A. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited[J]. Endocr Rev, 2016, 37(5): 467-520.
DAPAS M, LIN F T J, NADKARNI G N, et al. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis[J]. PLoS Med, 2020, 17(6): e1003132.
ABOELDALYL S, JAMES C, SEYAM E, et al. The role of chronic inflammation in polycystic ovarian syndrome-a systematic review and meta-analysis[J]. Int J Mol Sci, 2021, 22(5): 2734.
ROSTAMTABAR M, ESMAEILZADEH S, TOURANI M, et al. Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome[J]. J Cell Physiol, 2021, 236(2): 824-838.
SHAMSI M, GHAZAVI A, SAEEDIFAR A M, et al. The immune system’s role in PCOS[J]. Mol Biol Rep, 2022, 49(11): 10689-10702.
BARREA L, MARZULLO P, MUSCOGIURI G, et al. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome[J]. Nutr Res Rev, 2018, 31(2): 291-301.
ISHFAQ M, ZHANG W, LIU Y, et al. Baicalin attenuated Mycoplasma gallisepticum-induced immune impairment in chicken bursa of fabricius through modulation of autophagy and inhibited inflammation and apoptosis[J]. J Sci Food Agric, 2021, 101(3): 880-890.
DONG H X, WANG Q, WANG Z, et al. Impact of low frequency electro-acupuncture on glucose and lipid metabolism in unmarried PCOS women: a randomized controlled trial[J]. Chin J Integr Med, 2021, 27(10): 737-743.
STREITER S, FISCH B, SABBAH B, et al. The importance of neuronal growth factors in the ovary[J]. Mol Hum Reprod, 2016, 22(1): 3-17.
ZHAI Y, YAO G, RAO F, et al. Excessive nerve growth factor impairs bidirectional communication between the oocyte and cumulus cells resulting in reduced oocyte competence[J]. Reprod Biol Endocrinol, 2018, 16(1): 28.
MANTI M, PUI H P, EDSTRÖM S, et al. Excess of ovarian nerve growth factor impairs embryonic development and causes reproductive and metabolic dysfunction in adult female mice[J]. FASEB J, 2020, 34(11): 14440-14457.
QI X, YUN C, SUN L, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome[J]. Nat Med, 2019, 25(8): 1225-1233.
SHERMAN S B, SARSOUR N, SALEHI M, et al. Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis[J]. Gut Microbes, 2018, 9(5): 400-421.
LEGRO R S, ARSLANIAN S A, EHRMANN D A, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab, 2013, 98(12): 4565-4592.
GUO F, GONG Z, FERNANDO T, et al. The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in Chinese population[J]. Front Endocrinol (Lausanne), 2022, 13: 892125.
TANG R, DING X, ZHU J. Kisspeptin and polycystic ovary syndrome[J]. Front Endocrinol (Lausanne), 2019, 10: 298.
CUI P, MA T, TAMADON A, et al. Hypothalamic DNA methylation in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture[J]. Exp Physiol, 2018, 103(12): 1618-1632.
Effect of Peibu Qingli Decoction on gut microbiota in rats with polycystic ovary syndrome and insulin resistance
Discussion on treatment of polycystic ovary syndrome from the spleen and stomach based on the theory of “catch⁃up growth”
Clinical observation on the efficacy of Dr. Yu’s integrated Chinese and western medicine classification and treatment for polycystic ovary syndrome
Baicalin modulates gut microbiota and inhibits liver metastasis of colorectal cancer induced by high⁃fat diet
Research progress on bile acid metabolism and its receptors regulating intestinal immunity in ulcerative colitis and traditional Chinese herbal medicine intervention
Related Author
No data
Related Institution
Reproductive Medicine Center,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Heilongjiang University of Chinese Medicine
First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Department of Integrative Medicine, Obstetrics and Gynecology Hospital of Fudan University
School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine